Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Clinical outcomes of hepatitis B or C virus infections in patients with malignant lymphoma receiving autologous stem cell transplantation: on behalf of the Adult Lymphoma Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT).

Kato H, Kato K, Kim SW, Fukuda T, Mori T, Sawa M, Ohno Y, Yoshioka S, Iwato Y, Taji H, Onizuka M, Kurahashi S, Ichinohe T, Suzumiya J, Suzuki R.

Br J Haematol. 2019 Sep;186(6):e170-e175. doi: 10.1111/bjh.16050. Epub 2019 Jun 17. No abstract available.

PMID:
31206602
2.

Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.

Itonaga H, Ota S, Ikeda T, Taji H, Amano I, Hasegawa Y, Ichinohe T, Fukuda T, Atsuta Y, Tanizawa A, Kondo T, Miyazaki Y.

Leuk Res. 2018 Dec;75:50-57. doi: 10.1016/j.leukres.2018.11.003. Epub 2018 Nov 13.

PMID:
30458320
3.

Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.

Yamasaki S, Chihara D, Kim SW, Kawata T, Mizuta S, Ago H, Chou T, Yamane T, Uchiyama H, Oyake T, Miura K, Saito B, Taji H, Nakamae H, Miyamoto T, Fukuda T, Kanda J, Atsuta Y, Suzuki R.

Int J Hematol. 2019 Feb;109(2):175-186. doi: 10.1007/s12185-018-2560-x. Epub 2018 Nov 14.

PMID:
30430419
4.

Immunophenotypic analysis of adult patients with T-cell lymphoblastic lymphoma treated with hyper-CVAD.

Kato H, Yamamoto K, Kodaira T, Higuchi Y, Yamamoto H, Saito T, Taji H, Yatabe Y, Nakamura S, Kinoshita T.

Hematology. 2018 Mar;23(2):83-88. doi: 10.1080/10245332.2017.1355421. Epub 2017 Aug 4.

PMID:
28778131
5.

Deficiency of mitochondrial modulator MCJ promotes chemoresistance in breast cancer.

Fernández-Cabezudo MJ, Faour I, Jones K, Champagne DP, Jaloudi MA, Mohamed YA, Bashir G, Almarzooqi S, Albawardi A, Hashim MJ, Roberts TS, El-Salhat H, El-Taji H, Kassis A, O'Sullivan DE, Christensen BC, DeGregori J, Al-Ramadi BK, Rincon M.

JCI Insight. 2016 May 19;1(7). pii: e86873.

6.

Anti-CCR4 Monoclonal Antibody Mogamulizumab Followed by the GDP (Gemcitabine, Dexamethasone and Cisplatin) Regimen in Primary Refractory Angioimmunoblastic T-Cell Lymphoma.

Kato H, Yamamoto K, Higuchi Y, Yamamoto H, Saito T, Taji H, Yatabe Y, Nakamura S, Kinoshita T.

Chemotherapy. 2017;62(1):19-22. Epub 2016 May 27.

PMID:
27226129
7.

Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy.

Murakami S, Kato H, Higuchi Y, Yamamoto K, Yamamoto H, Saito T, Taji H, Yatabe Y, Nakamura S, Kinoshita T.

Ann Hematol. 2016 Aug;95(8):1259-69. doi: 10.1007/s00277-016-2690-2. Epub 2016 May 25.

PMID:
27220639
8.

Influence of melphalan plus fludarabine-conditioning regimen in elderly patients aged ⩾55 years with hematological malignancies.

Miyao K, Sawa M, Kuwatsuka Y, Ozawa Y, Kato T, Kohno A, Sao H, Nishida T, Iida H, Naito K, Tsurumi H, Taji H, Mizuta S, Kusumoto S, Nakase K, Morishita Y, Kawashima N, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group.

Bone Marrow Transplant. 2016 Jan;51(1):157-60. doi: 10.1038/bmt.2015.235. Epub 2015 Oct 5. No abstract available.

PMID:
26437064
9.

The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.

Kako S, Izutsu K, Kato K, Kim SW, Mori T, Fukuda T, Kobayashi N, Taji H, Hashimoto H, Kondo T, Sakamaki H, Morishima Y, Kato K, Suzuki R, Suzumiya J; Adult Lymphoma Working Group of the Japanese Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2015 Feb;90(2):132-8. doi: 10.1002/ajh.23897. Epub 2014 Nov 24.

10.

Salvage therapy with single agent L-asparaginase followed by local irradiation in an elderly patient with CD56-positve primary isolated extramedullary T-cell lymphoblastic lymphoma of the sinus.

Hirano D, Kato H, Kodaira T, Yatabe Y, Ueda N, Murakami S, Higuchi Y, Taji H, Nakamura S, Yamamoto K, Kinoshita T.

Ann Hematol. 2015 Jan;94(1):173-5. doi: 10.1007/s00277-014-2128-7. Epub 2014 Jun 20. No abstract available.

PMID:
24947796
11.

Intravenous administration of manuka honey inhibits tumor growth and improves host survival when used in combination with chemotherapy in a melanoma mouse model.

Fernandez-Cabezudo MJ, El-Kharrag R, Torab F, Bashir G, George JA, El-Taji H, al-Ramadi BK.

PLoS One. 2013;8(2):e55993. doi: 10.1371/journal.pone.0055993. Epub 2013 Feb 7.

12.

Interstitial pneumonia after autologous hematopoietic stem cell transplantation in B-cell non-hodgkin lymphoma.

Kato H, Yamamoto K, Taji H, Oki Y, Chihara D, Seto M, Kagami Y, Morishima Y.

Clin Lymphoma Myeloma Leuk. 2011 Dec;11(6):483-9. doi: 10.1016/j.clml.2011.06.011. Epub 2011 Oct 5.

PMID:
21978956
13.

Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas.

Kato H, Yamamoto K, Oki Y, Ine S, Taji H, Chihara D, Kagami Y, Seto M, Morishima Y.

Leukemia. 2012 Jan;26(1):166-9. doi: 10.1038/leu.2011.183. Epub 2011 Aug 5. No abstract available. Erratum in: Leukemia. 2013 Aug;27(8):1792.

PMID:
21818114
14.

Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: analyses with competing risk regression model.

Chihara D, Oki Y, Matsuo K, Onoda H, Taji H, Yamamoto K, Morishima Y.

Leuk Lymphoma. 2011 Dec;52(12):2270-5. doi: 10.3109/10428194.2011.596966. Epub 2011 Jul 12.

PMID:
21745170
15.

High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma.

Chihara D, Oki Y, Onoda H, Taji H, Yamamoto K, Tamaki T, Morishima Y.

Int J Hematol. 2011 Apr;93(4):502-508. doi: 10.1007/s12185-011-0822-y. Epub 2011 Apr 6.

PMID:
21512731
16.

Nodal relapse after Helicobacter pylori eradication in a patient with primary localized gastric mucosa-associated lymphoid tissue lymphoma.

Kato H, Kagami Y, Kodaira T, Oka S, Oki Y, Chihara D, Taji H, Yatabe Y, Nakamura T, Nakamura S, Seto M, Yamamoto K, Morishima Y.

Am J Gastroenterol. 2011 Mar;106(3):549-51. doi: 10.1038/ajg.2010.457. No abstract available.

PMID:
21378774
17.

Clinical impact and predisposing factors of delayed-onset neutropenia after autologous hematopoietic stem-cell transplantation for B-cell non-Hodgkin lymphoma: association with an incremental risk of infectious events.

Kato H, Yamamoto K, Matsuo K, Oki Y, Taji H, Kuwatsuka Y, Seto M, Kagami Y, Morishima Y.

Ann Oncol. 2010 Aug;21(8):1699-705. doi: 10.1093/annonc/mdq008. Epub 2010 Feb 19.

PMID:
20172906
18.

Primary gastric diffuse large B-cell Lymphoma (DLBCL): analyses of prognostic factors and value of pretreatment FDG-PET scan.

Chihara D, Oki Y, Ine S, Kato H, Onoda H, Taji H, Kagami Y, Yamamoto K, Morishima Y.

Eur J Haematol. 2010 Jun;84(6):493-8. doi: 10.1111/j.1600-0609.2010.01426.x. Epub 2010 Feb 9.

PMID:
20148943
19.

Favorable consolidative effect of high-dose melphalan and total-body irradiation followed by autologous peripheral blood stem cell transplantation after rituximab-containing induction chemotherapy with in vivo purging in relapsed or refractory follicular lymphoma.

Kato H, Taji H, Ogura M, Kagami Y, Oki Y, Tsujimura A, Fuwa N, Kodaira T, Seto M, Yamamoto K, Morishima Y.

Clin Lymphoma Myeloma. 2009 Dec;9(6):443-8. doi: 10.3816/CLM.2009.n.087.

PMID:
19951884
20.

Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy.

Chihara D, Oki Y, Ine S, Yamamoto K, Kato H, Taji H, Kagami Y, Yatabe Y, Nakamura S, Morishima Y.

Leuk Lymphoma. 2009 Dec;50(12):1999-2004. doi: 10.3109/10428190903318311.

PMID:
19860627
21.

R-CHOP therapy for MALT lymphoma of the rectum.

Chihara D, Kagami Y, Oki Y, Kato H, Onoda H, Ine S, Taji H, Yamamoto K, Morishima Y.

Eur J Haematol. 2010 Jan 1;84(1):84-6. doi: 10.1111/j.1600-0609.2009.01346.x. Epub 2009 Sep 8. No abstract available.

PMID:
19737307
22.

Donor single nucleotide polymorphism in the CCR9 gene affects the incidence of skin GVHD.

Inamoto Y, Murata M, Katsumi A, Kuwatsuka Y, Tsujimura A, Ishikawa Y, Sugimoto K, Onizuka M, Terakura S, Nishida T, Kanie T, Taji H, Iida H, Suzuki R, Abe A, Kiyoi H, Matsushita T, Miyamura K, Kodera Y, Naoe T.

Bone Marrow Transplant. 2010 Feb;45(2):363-9. doi: 10.1038/bmt.2009.131. Epub 2009 Jun 15.

PMID:
19525985
23.

Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations.

Awad MA, Denic S, El Taji H.

Ann N Y Acad Sci. 2008 Sep;1138:146-54. doi: 10.1196/annals.1414.021.

PMID:
18837895
24.

The use of a vacuum-assisted biopsy device (Mammotome) in the early detection of breast cancer in the United Arab Emirates.

Faour I, Al-Salam S, El-Terifi H, El Taji H.

Ann N Y Acad Sci. 2008 Sep;1138:108-13. doi: 10.1196/annals.1414.016.

PMID:
18837890
25.

Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.

Oki Y, Yamamoto K, Kato H, Kuwatsuka Y, Taji H, Kagami Y, Morishima Y.

Eur J Haematol. 2008 Dec;81(6):448-53. doi: 10.1111/j.1600-0609.2008.01129.x. Epub 2008 Aug 6.

PMID:
18691256
26.

Prognostic value of serum soluble interleukin-2 receptor level in patients with diffuse large B cell lymphoma, treated with CHOP- or RCHOP-based therapy.

Oki Y, Kato H, Matsuo K, Kuwatsuka Y, Taji H, Yamamoto K, Kagami Y, Morishima Y.

Leuk Lymphoma. 2008 Jul;49(7):1345-51. doi: 10.1080/10428190802108888.

PMID:
18452099
27.

Fundamental studies on electrokinetic chromatography with PEGylated phospholipid micelles.

Kitagawa F, Hasegawa T, Taji H, Onoue S, Tsuda Y, Otsuka K.

Anal Sci. 2008 Jan;24(1):155-9.

28.

Primary hepatic follicular lymphoma : a case report and discussion of chemotherapy and favorable outcomes.

Gomyo H, Kagami Y, Kato H, Kawase T, Ohshiro A, Oyama T, Kamiya Y, Taji H, Nakamura S, Ogura M, Morishima Y.

J Clin Exp Hematop. 2007 Nov;47(2):73-7.

29.

Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

Oki Y, Ogura M, Kato H, Kikuchi A, Taji H, Kagami Y, Oshiro A, Tsujimura A, Yamamoto K, Morishima Y.

Cancer Sci. 2008 Jan;99(1):179-84. Epub 2007 Nov 7.

30.

Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma.

Ogawa Y, Tobinai K, Ogura M, Ando K, Tsuchiya T, Kobayashi Y, Watanabe T, Maruyama D, Morishima Y, Kagami Y, Taji H, Minami H, Itoh K, Nakata M, Hotta T.

Cancer Sci. 2008 Jan;99(1):140-4. Epub 2007 Oct 27.

31.

Synthesis of enantiopure 2-aryl-2-methoxypropionic acids and determination of their absolute configurations by X-ray crystallography.

Sekiguchi S, Naito J, Taji H, Kasai Y, Sugio A, Kuwahara S, Watanabe M, Harada N.

Chirality. 2008 Mar;20(3-4):251-64.

PMID:
17559106
32.

New route to enantiopure MalphaNP acid, a powerful resolution and chiral 1H NMR anisotropy reagent.

Naito J, Taji H, Sekiguchi S, Watanabe M, Kuwahara S, Watanabe M, Harada N.

Chirality. 2007 May 15;19(5):335-43.

PMID:
17354261
33.

High-dose chemotherapy and autologous peripheral blood stem cell transfusion for adult and adolescent patients with small round cell sarcomas.

Yamada K, Takahashi M, Ogura M, Kagami Y, Taji H, Kamiya Y, Sugiura H, Morishima Y.

Bone Marrow Transplant. 2007 Apr;39(8):471-6. Epub 2007 Mar 5.

PMID:
17334381
34.

Electrophoretic analysis of proteins and enantiomers using capillaries modified by a successive multiple ionic-polymer layer (SMIL) coating technique.

Kitagawa F, Kamiya M, Okamoto Y, Taji H, Onoue S, Tsuda Y, Otsuka K.

Anal Bioanal Chem. 2006 Oct;386(3):594-601. Epub 2006 May 16.

PMID:
16703385
35.

Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation.

Atsuta Y, Suzuki R, Yamamoto K, Terakura S, Iida H, Kohno A, Naoe T, Yano K, Wakita A, Taji H, Hamaguchi M, Kodera Y, Sao H, Morishima Y, Hamajima N, Morishita Y.

Bone Marrow Transplant. 2006 Feb;37(3):289-96. Erratum in: Bone Marrow Transplant. 2006 Oct;38(8):583.

PMID:
16400341
36.

CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases.

Kawase T, Hamazaki M, Ogura M, Kawase Y, Murayama T, Mori Y, Nagai H, Tateno M, Oyama T, Kamiya Y, Taji H, Kagami Y, Naoe T, Takahashi T, Morishima Y, Nakamura S.

Int J Hematol. 2005 May;81(4):323-9.

PMID:
15914364
37.

Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis.

Shimada K, Yokozawa T, Atsuta Y, Kohno A, Maruyama F, Yano K, Taji H, Kitaori K, Goto S, Iida H, Morishima Y, Kodera Y, Naoe T, Morishita Y.

Bone Marrow Transplant. 2005 Jul;36(2):115-21.

PMID:
15908969
38.

The effects of aromatic substituents on the chromatographic enantioseparation of diarylmethyl esters with the whelk-O1 chiral stationary phase.

Job GE, Shvets A, Pirkle WH, Kuwahara S, Kosaka M, Kasai Y, Taji H, Fujita K, Watanabe M, Harada N.

J Chromatogr A. 2004 Nov 5;1055(1-2):41-53.

PMID:
15560478
39.

Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma.

Matsuo K, Hamajima N, Suzuki R, Ogura M, Kagami Y, Taji H, Yasue T, Mueller NE, Nakamura S, Seto M, Morishima Y, Tajima K.

Am J Hematol. 2004 Dec;77(4):351-7.

40.

MalphaNP acid, a powerful chiral molecular tool for preparation of enantiopure alcohols by resolution and determination of their absolute configurations by the (1)H NMR anisotropy method.

Kasai Y, Taji H, Fujita T, Yamamoto Y, Akagi M, Sugio A, Kuwahara S, Watanabe M, Harada N, Ichikawa A, Schurig V.

Chirality. 2004 Nov;16(9):569-85.

PMID:
15390086
41.

Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in Japanese.

Hishida A, Matsuo K, Tajima K, Ogura M, Kagami Y, Taji H, Morishima Y, Emi N, Naoe T, Hamajima N.

Leuk Lymphoma. 2004 May;45(5):957-64.

PMID:
15291355
42.

Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.

Nishida T, Hamaguchi M, Hirabayashi N, Haneda M, Terakura S, Atsuta Y, Imagama S, Kanie T, Murata M, Taji H, Suzuki R, Morishita Y, Kodera Y.

Bone Marrow Transplant. 2004 Jun;33(11):1143-50.

PMID:
15077133
44.

Polymorphism in the hMSH2 gene (gIVS 12-6T-->C) and risk of non-Hodgkin lymphoma in a Japanese population.

Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, Taji H, Morishima Y, Emi N, Tajima K.

Cancer Genet Cytogenet. 2003 Nov;147(1):71-4.

PMID:
14580774
45.

Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation.

Yanada M, Yamamoto K, Emi N, Naoe T, Suzuki R, Taji H, Iida H, Shimokawa T, Kohno A, Mizuta S, Maruyama F, Wakita A, Kitaori K, Yano K, Hamaguchi M, Hamajima N, Morishima Y, Kodera Y, Sao H, Morishita Y.

Bone Marrow Transplant. 2003 Oct;32(8):801-7.

PMID:
14520425
46.

Pilot phase I/II study of new salvage therapy (CHASE) for refractory or relapsed malignant lymphoma.

Ogura M, Kagami Y, Taji H, Suzuki R, Miura K, Takeuchi T, Morishima Y.

Int J Hematol. 2003 Jun;77(5):503-11.

PMID:
12841390
47.

Phenotypic analysis of peripheral T/NK cell lymphoma: study of 408 Japanese cases with special reference to their anatomical sites.

Ichimura K, Kagami Y, Suzuki R, Kojima M, Yoshino T, Ohshima K, Koike K, Kondo E, Taji H, Ogura M, Morishima Y, Akagi T, Takahashi T, Nakamura S.

Pathol Int. 2003 Jun;53(6):333-44.

PMID:
12787307
48.

Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens.

Akatsuka Y, Nishida T, Kondo E, Miyazaki M, Taji H, Iida H, Tsujimura K, Yazaki M, Naoe T, Morishima Y, Kodera Y, Kuzushima K, Takahashi T.

J Exp Med. 2003 Jun 2;197(11):1489-500. Epub 2003 May 27.

49.

Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma.

Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, Taji H, Morishima Y, Emi N, Tajima K.

Haematologica. 2003 Feb;88(2):159-66.

50.

Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients.

Oyama T, Ichimura K, Suzuki R, Suzumiya J, Ohshima K, Yatabe Y, Yokoi T, Kojima M, Kamiya Y, Taji H, Kagami Y, Ogura M, Saito H, Morishima Y, Nakamura S.

Am J Surg Pathol. 2003 Jan;27(1):16-26.

PMID:
12502924

Supplemental Content

Support Center